BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9129806)

  • 1. Molecular dynamics simulations of Leu-enkephalin in water and DMSO.
    van der Spoel D; Berendsen HJ
    Biophys J; 1997 May; 72(5):2032-41. PubMed ID: 9129806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17O NMR and FT-IR study of the ionization state of peptides in aprotic solvents. Application to Leu-enkephalin.
    Gerothanassis IP; Birlirakis N; Karayannis T; Tsikaris V; Sakarellos-Daitsiotis M; Sakarellos C; Vitoux B; Marraud M
    FEBS Lett; 1992 Feb; 298(2-3):188-90. PubMed ID: 1544442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A conformational analysis of leucine enkephalin as a function of pH.
    Aburi M; Smith PE
    Biopolymers; 2002 Aug; 64(4):177-88. PubMed ID: 12115135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural characterization of methionine and leucine enkephalins by hydrogen/deuterium exchange and electrospray ionization tandem mass spectrometry.
    Cai X; Dass C
    Rapid Commun Mass Spectrom; 2005; 19(1):1-8. PubMed ID: 15568184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orientation and conformational preference of leucine-enkephalin at the surface of a hydrated dimyristoylphosphatidylcholine bilayer: NMR and MD simulation.
    Chandrasekhar I; van Gunsteren WF; Zandomeneghi G; Williamson PT; Meier BH
    J Am Chem Soc; 2006 Jan; 128(1):159-70. PubMed ID: 16390143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational study of [Leu5]-enkephalin by laser Raman spectroscopy.
    Han SL; Stimson ER; Maxfield FR; Scheraga HA
    Int J Pept Protein Res; 1980 Sep; 16(3):173-81. PubMed ID: 7461899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The probability distribution of side-chain conformations in [Leu] and [Met]enkephalin determines the potency and selectivity to mu and delta opiate receptors.
    Nielsen BG; Jensen MØ; Bohr HG
    Biopolymers; 2003; 71(5):577-92. PubMed ID: 14635098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic space structure of the Leu-enkephalin molecule in DMSO solution.
    Vesterman B; Saulitis J; Betins J; Liepins E; Nikiforovich GV
    Biochim Biophys Acta; 1989 Oct; 998(2):204-9. PubMed ID: 2790063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational preference of Leu side chain in melanostatin in DMSO.
    Sasidhar YU; Dhingra MM; Saran A
    Indian J Biochem Biophys; 1990 Apr; 27(2):69-75. PubMed ID: 1972373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Water network dynamics at the critical moment of a peptide's beta-turn formation: a molecular dynamics study.
    Karvounis G; Nerukh D; Glen RC
    J Chem Phys; 2004 Sep; 121(10):4925-35. PubMed ID: 15332928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring Conformational Preferences of Leu-enkephalin Using the Conformational Search and Double-Hybrid DFT Energy Calculations.
    Park HS; Byun BJ; Kang YK
    ACS Omega; 2022 Aug; 7(31):27755-27768. PubMed ID: 35967045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 270-MHz 1H nuclear-magnetic-resonance study of met-enkephalin in solvent mixtures. Conformational transition from dimethylsulphoxide to water.
    Zetta L; Cabassi F
    Eur J Biochem; 1982 Feb; 122(1):215-22. PubMed ID: 7060566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and biological implications of the binding of Leu-enkephalin and its metal derivatives to opioid receptors.
    Wieberneit F; Korste A; Albada HB; Metzler-Nolte N; Stoll R
    Dalton Trans; 2013 Jul; 42(27):9799-802. PubMed ID: 23525213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of Leu-Enkephalin analog with (4-Carboxamido)phenylalanine substituted for tyrosine: a molecular dynamics study.
    Wang YC; Wu YC; Yeh CC; Hwang CC
    Biopolymers; 2007 Jun; 86(3):231-9. PubMed ID: 17377963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optically active aromatic amino acids. Part VI. Synthesis and properties of (Leu5)-enkephalin analogues containing O-methyl-L-tyrosine1 with ring substitution at position 3'.
    Arnold ZS; Schiller PW
    J Pept Sci; 2000 Jun; 6(6):280-9. PubMed ID: 10912908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and conformational studies of a beta-turn mimetic incorporated in Leu-enkephalin.
    Blomberg D; Hedenström M; Kreye P; Sethson I; Brickmann K; Kihlberg J
    J Org Chem; 2004 May; 69(10):3500-8. PubMed ID: 15132562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipophilic derivatives of leu-enkephalinamide: in vitro permeability, stability and in vivo nasal delivery.
    Cros CD; Toth I; Blanchfield JT
    Bioorg Med Chem; 2011 Feb; 19(4):1528-34. PubMed ID: 21273080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of amino acid chirality and the chemical linker on the cell permeation characteristics of cyclic prodrugs of opioid peptides.
    Liederer BM; Fuchs T; Vander Velde D; Siahaan TJ; Borchardt RT
    J Med Chem; 2006 Feb; 49(4):1261-70. PubMed ID: 16480263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational polymorphism of the PrP106-126 peptide in different environments: a molecular dynamics study.
    Villa A; Mark AE; Saracino GA; Cosentino U; Pitea D; Moro G; Salmona M
    J Phys Chem B; 2006 Jan; 110(3):1423-8. PubMed ID: 16471693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of solvents and leucine configuration at position 5 on tryptophan fluorescence in cyclic enkephalin analogues.
    Malicka J; Groth M; Karolczak J; Czaplewski C; Liwo A; Wiczk W
    Biopolymers; 2001 Apr; 58(4):447-57. PubMed ID: 11180057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.